Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.06 BRL | -15.40% | -17.31% | -12.81% |
May. 09 | Braskem Shares Fall; Q1 Swings to Loss, Revenue Drops | MT |
May. 09 | Braskem S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.68 for the current period. Therefore, the company is undervalued.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company has insufficient levels of profitability.
- One of the major weak points of the company is its financial situation.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.81% | 2.97B | C+ | ||
+5.97% | 105B | A- | ||
-4.43% | 63.99B | A- | ||
+51.90% | 42.95B | B | ||
+17.44% | 39.2B | B | ||
+6.62% | 33.01B | A- | ||
+13.00% | 20.33B | B- | ||
+15.64% | 17.29B | C+ | ||
+22.55% | 15.72B | B- | ||
+7.34% | 14.72B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BRKM5 Stock
- Ratings Braskem S.A.